The guiding thread of the event 2019 will be

Next Generation Bioproduction

Focus Topic I:
Bioproduction in the Sense of Bioeconomy

Focus Topic II:
Advances in Biomanufacturing and Upcoming Biopharmaceuticals

 

Keynote Speakers

Jay Keasling

  • Professor of Biochemical Engineering, Department of Chemical & Biomolecular Engineering, University of California, Berkeley, USA
  • CSTO for Biosciences and Faculty Senior Scientist, Lawrence Berkeley National Laboratory, USA
  • CEO, Joint BioEnergy Institute, USA
More Information

Akihiko Kondo

    • Director of Biorefinery Center,
    • Director of Engineering Biology Research Center
    • Professor at Kobe University, Japan
    • Cell Factory Research Team, RIKEN Center for Sustainable Resource Science, Yokohama, Japan
More Information

Thomas Haas

  • Vice President Science & Technology, Evonik Creavis GmbH, Germany
More Information

Marcel Wubbolts

  • Chief Technology Officer, Corbion Group Netherlands bv, The Netherlands
More Information

Chen George Guo-Qiang

  • Funding Director at the Center of Synthetic and Systems Biology, Tsinghua University, China
  • Professor at the School of Life Sciences, Tsinghua University, China
  • Chair Professor at Manchester Institute of Biotechnology, England
More Information

Christian Eckermann

    • Senior Vice President and Site Head of Biopharma Austria at Boehringer Ingelheim RCV, Austria
More Information

Hanspeter Rottensteiner

  • Head of Research Gene Therapy, Drug Discovery Austria (Takeda)
More Information

Chris Savile

  • Vice President of Commercial Operations at Willow Biosciences Inc., Canada
More Information

Program & Speakers

 
Focus on Bioproduction in the Sense of Bioeconomy
Focus on Advances in Biomanufacturing & Upcoming Biopharmaceuticals
Others:Out of the box topics
IDHourSessionType
I10:15 – 11:45

The Learnings of H2020 and the Forecast to “Horizon Europe” (FP9)

How did the 8th framework programme of the European commission perform and what are the learnings for “Horizon Europe”? The Austrian NCP are talking about the upcoming episode of European research and innovation projects. Use the opportunity, take part and gain your competitive advantage for your future proposals.

Speakers:
Andrea Höglinger (FFG)
Nelo Emerencia (BIC, EC)
Special Session
II10:15 – 11:45

KETBIO EU Project Partnering

KETBIO onsite partnering is an innovation biotechnology matchmaking to meet cooperation partners. This special EU-partnering will connect you with funding specialists from the bio-economy community. KETBIO offers the opportunity to meet partners for potential projects, learn about EU-funded projects or present them. Identify cooperation partners on the basis of your needs and arrange an onsite and online meeting. For further details just register for ESIB conference 2019 and join us @ketbio.
Special Session
Registration Reception & Poster Session
12:30

Welcome Address:


Speakers:
Mathias Drexler (CEO acib)
Bernd Nidetzky (CSO acib)
Plenary
0113:00 – 14:30

Trends in Politics

What are the future strategies for bioeconomy on political level? Who are the influencers? The opening session of esib 2019 will be dedicated to the triangle of politics, science and industry and their interactions for efficient bioeconomic production. Do not miss the roundtable discussion with top-ranking Austrian politicians disclosing their future plans.

Speakers:
Jürgen Schneider (BMNT, Sektionschef Bioökonomie)
TBA
Plenary
Coffee Break & Poster Session
0215:15 – 17:15

Trends in Science

What are the burning issues in an ever-changing scientific landscape? What are the challenges and needs to be addressed for the future development of industrial biotechnology and bioeconomy? Take part in discussing the most promising trends in science.

Speakers:
Guo-Qiang Chen (CSSB, China)
Jay Keasling (Univ. California, Berkley, USA)
Akihiko Kondo (Kobe University, Japan)
Plenary
Coffee Break & Poster Session
0318:00 – 20:00

Trends in Industry

Academia meets industry and both shape the future trends of industrial biotechnology. Experience the challenges of industrial biotechnology from the points of view of global players in Europe‘s biotech industry and of small but highly innovative companies.

Speakers:
Hanspeter Rottensteiner (Gene Therapy, Takeda)
Christopher Savile (Willow Biosciences)
Christian Eckermann (Boehringer Ingelheim RCV GmbH & Co KG)
Plenary
21:00

Chilling Life Science

Dom im Berg
IDHourSessionType
WORKSHOP SESSION 1
04
9:00 – 11:00

CO2 – the Next Generation Feedstock for valuable Products

Increasing release of carbon dioxide (CO2) has a dramatic impact on global climate. The utilization of CO2 as a carbon resource is coming into focus of R&D. Which products could be derived from CO2? What are the economic, ecologic and energy-political issues that should be linked to scientific agendas? Join in and get a clearer picture of the key stakeholders in a circular economy to create value from CO2.

Speakers:
Damien Dallemagne (CO2 Value Europe)
Björn Heijstra (Lanzatech)
Yagut Allahverdiyeva-Rinne (University of Turku)
TBA
Parallel Workshop
05
9:00 – 11:00

Virtual Bioprocessing – the Future of Quality by Design

Smart facilities and Industry 4.0 are becoming reality in various industry fields. Connectivity of data, accessibility of information and process understanding – all leads to more automated and better controls of manufacturing. However, the modelling of processes or the creation of a digital twin are still lacking. What are suitable models to understand production processes? What is required by authorities such as FDA or EMEA? Get informed about new trends in the sense of the Quality by Design (QbD) approach.

Speakers:
Julita Panek (Siemens AG)
Moritz von Stosch (GlaxoSmithKline)
Mark Dürkop (Novasign Solutions)
TBA
Parallel Workshop
06
9:00 – 11:00

Designing Cell Factories for a Circular Economy

Using the tools of synthetic biology, metabolic pathways can be redesigned in microbes to construct cell factories that produce high value molecules for diverse applications. The extensive use of omics data, bioinformatic tools and metabolic modelling are common features of many projects that aim to construct such cell factories. A panel of selected H2020 projects discuss their central question: How to engineer cell factories to enable them to use sustainable carbon sources and to increase yields?

Speakers:
Jens Nielsen (Chalmers Univ. Sweden, CHASSY)
Eriko Takano (Univ. Manchester, TOPCAPI)
Markus Herrgard (Novo Nordisk Foundation, DD-DeCaf)
H2020 Special Workshop
07
9:00 – 11:00

Novel Food and Cosmetics Ingredients – What are the Quality Requirements of Tomorrow?

How do we have to think next generation product quality? What needs to be taken into account for a future product viable between regulatory demands (novel food, health claims, REACH etc.) and customer awareness or policy influence (product environmental footprint, maybe even social life cycle assessment). Get up-to-date information from validation authorities and experts in the field, listen to their insights and get inspired by new product and process design trends.

Speakers:
Gerald Renner (Cosmetics Europe)
Nicoleta Pasecinic (Pen&Tec Consulting)
TBA
Parallel Workshop
IV
9:00 – 11:00

KETBIO Workshop

KETBIO, a H2020 funded CSA project involving 7 partners across Europe, aims to reduce time to market and speed up commercial outcomes from EU-funded Biotechnology projects by various mechanisms and establishing a novel biotechnology cluster.

In this workshop you will hear about the KETBIO aims and deliverables and how you can benefit from joining the cluster and online platform. The latest, innovative IB projects, encompassing novel feedstocks and process technologies to new bio-based products and emerging trends will be showcased.

Speakers:
TBA
Special Session
Coffee Break
08
11:15 – 12:00

Science Flash

You have an idea you want to place on the market? You have an outstanding new finding you want to present? be precise and be to the point in a powerful speed presentation.

Plenary
Lunch Break & Poster Session
WORKSHOP SESSION 2
09
13:30 – 15:30

Valorizing Oil and Fat Streams through Next Generation Biocatalysis

Biological oils and fats are a high-energy and high-volume production stream stretching beyond the food and feed sectors. Enzymatic modification of (un)saturated fatty acids yields in fuels, flavours & fragrances, pharmaceuticals, skin care products, materials, and plastics that are typically derived from fossil resources. How much of crude oil will next generation bioproduction - based on microbial/algaeal fermentation and enzymatic upcycling – can be replaced during the next decade?

Speakers:
Andreas Schirmer (Genomatica)
TBA
Parallel Workshop
10
13:30 – 15:30

Artificial Intelligence in Biotechnology – the Future of Bioprocesses

Handling of big data becomes a key element for biotechnology, bioprocess engineering and medical healthcare. Modern artificial intelligence allows to analyze large volumes of data in many domains, in ways that were inaccessible until now. How can we use artificial intelligence and machine learning in different fields (eg pharma, diagnostics, drug development)? Join in and get ready for modern biotechnology research.

Speakers:
Christian Gruber (Innophore)
Andreas Persidis (Biovista Inc.)
Andreas Posch (Ares Genetics GmbH)
TBA
Parallel Workshop
11
13:30 – 15:30

Converting Projects of Today into Products for the Market of Tomorrow

Projects under the H2020 framework program strongly focused on impact. In practice, EU project participants are facing the challenge of taking the ideas from the projects to market. Is there any formula for success? What are the recommendations of those, who have been successful? Get some practical advice for making the best out of your project.

Speakers:
Daniel Lopez (CSIC, RAFTS4LIPIDS)
Irina Borodina (DTU, OLEFINE/PACMEN)
Bruno Ferreira (Biotrend, YEASTDOC)
TBA
H2020 Special Workshop
12
13:30 – 15:30

Next Generation Microbials – the Potential of Microbiome Research

The microbiome is strongly connected with sustainable production in agriculture and industry, our food chain, and 'one health' issues. Moreover, it is currently one of the most important research fields emerging within different disciplines. What are the promising approaches for meeting the demands of the European bioeconomy strategy? Project leaders and industry pioneers in the field of microbiome science share their experience and knowledge.

Speakers:
Anders Gram (Indigo AG)
Lise Korsten (Univ. of Pretoria)
Michael Schloter (HMZ/TU München)
Parallel Workshop
Coffee Break
WORKSHOP SESSION 3
13
16:00 – 18:00

Next Generation Biocatalytic Production

Various biocatalytic reactions (e.g. asymmetric ketone reduction, asymmetric amination of ketones) have become state of the art in industry as well as in academia. For selected cases enzyme engineering was required to adapt the enzyme to the process, which is today’s approach in contrast to old time adapting the process to the enzyme. What are the current challenges for biocatalysis? What are the next reactions to be transferred to industrial scale? What is the state for using light and electricity as energy source for biocatalytic reactions? Get an update.

Speakers:
Nick Turner (Univ. Manchester)
Radka Snajdrova (Novartis)
Volker Sieber (TU München)
Bruno Bühler (UFZ Leipzig)
Parallel Workshop
V
16:00 – 18:00

Challenges in Design and Production of Next Generation Vaccines

Climate change, emerging and re-emerging viruses are becoming an urgent threat for animal and human health. New concepts for the development of Next-Generation vaccines are highly needed. Our experts highlight recent technologies for production, up-scaling and downstream processing for industrial demands. How long does it take from test tube to patient? Get informed about mandatory steps on the long way to market authorization.

Speakers:
Lee Smith (GreyRigge, UK)
Miriam Klausberger (BOKU Vienna)
Dieter Palmberger (acib GmbH)
Patricia Aguilar (BOKU Vienna)
Katrin Reiter (acib GmbH)
acib/BOKU Special Workshop
14
16:00 – 18:00

Next Generation Start-up Bootcamp

You started up with your own company? First mission accomplished. But how to proceed to bring your success to the next level? Which competences are essential? Take the opportunity to learn from a business angel and to meet some biotech start-ups at different stages of their foundation. Find out how the others dealed with fundings, marketing activities and building up networks.

Speakers:
Tina Gruber Mücke (Univ. Applied Sciences Lower Austria)
Christian Burgard (ArthroKinetics)
Barbara Sladek (myBioma GmbH)
Martin Kern (Merck GmbH)
Ayla Arslan (Univ. Sarajevo)
Parallel Workshop
15
16:00 – 18:00

Producing Trends in Open Schooling – Interactive

Bubbling with ideas? Let’s talk about them! This year we will talk about efficient ways to attract the “next generation biotechnologists”. Discuss your insights and concepts. Stimulate each other during lively face-to-face discussions in small groups. Be guest in our World Café, take a seat and be part of producing future trends.

Speakers:
Brigitte Gschmeidler (OpenScience)
Maria Strommer (akzente)
World-Café
Poster Session & Get-together
18:15 – 19:45

Science Meets Economy

Are you looking for new collaborative partnerships? A guided matchmaking event organised by the SFG and the Enterprise Europe Network is a unique opportunity to generate new business contacts and to develop new ideas. Select interesting prospective partners and pre-book 15-minute meetings with them in advance of the event. The Science Meets Economy B2B event has a separate website. For more details and registration please visit https://esib2019.b2match.io/
Matchmaking
20:30

Gala Academia

Schloßbergrestaurant
Social
IDHourSessionType
8:30 – 10:00

Biotech Breakfast & Poster Session

Let the day begin! Breakfast is the most important meal of the day so let’s get together and start the last day of our summit with a delicious, typical styrian breakfast to delight body & soul. (included in registration fee)
Social & Poster Session
WORKSHOP SESSION 4
16
10:00 – 12:00

Continuous Downstream Processing for Biomolecules of the Future

Continuous Downstream Processing is nowadays making its way into the process development departments for biomolecules. We review the current status of integration of continuous downstream processing and look at the future challenges of what’s still missing for a fully continuous process. For which unit operations is the technology already available, for which unit operations are we missing important technologies, and to what extend is the integration of different unit operations into one seamless process possible?

Speakers:
Gorazd Hribar (Lek/Novartis)
Michael Philipps (Merck Millipore)
Jason Walther (Sanofi)
Ana Azevedo (IST Lisboa)
Parallel Workshop
17
10:00 – 12:00

Next Generation Biopolymers - the Materials of the Future?

Yesterday there was plastic made of oil. Today we focus on recycling. What will be tomorrow? How can upcycling provide a greener future? Does polylactic acid really change the world of packing materials? What is the potential of biotechnology and enzymes in this context? The number of innovative ideas of creating biopolymers out of new resources and development of coating or surface activation systems seem to be endless. Join a selected bunch of experts in a journey to the engineers never never land.

Speakers:
Guo-Qiang Chen (CSSB, China)
Dr. Ale Pellis (University of York)
Prof. Manfred Zinn (HES-SO Valais-Wallis)
Andreas Künkel (BASF)
Parallel Workshop
18
10:00 – 12:00

Novel Biorefinery Concepts

In order to produce materials and chemicals sustainable biorefinery concepts are of importance.
How to implement a sustainable and circular bioeconomy? How can bioeconomy concepts be introduced into different market segments spanning from cosmetics to cement industry? In this session different industry sectors are presenting their bioeconomy strategy. Which concepts and solutions are economically viable and what limiting barriers can be identified? Is a high oil price the only critical parameter for a successful business model? What other advantages do products have which are produced by a sustainable and circular biorefinery?

Speakers:
Anja Ebenschweiger (Lafarge)
Nic Lindley (A* Star)
Markus Ellersdorfer (Montan Univ. Leoben)
Parallel Workshop
VI
10:00 – 12:00

Computer-aided design of cell factories

Cell factory development projects often use omics data and modeling to identify bottlenecks and suggest new design strategies. However, the software platforms that are currently available for data-driven modeling and design support only limited use of data and are not end-user friendly. What are newest developments in computer-aided cell factory design? How can cutting edge software tools help you in developing your next cell factory? Join this workshop to learn hands-on skills for employing computer-aided cell factory design in your projects.
Participation conditions: binding registration until 15th October 2019; for equipment please use your own laptop.

Speakers:
TBA
Special Session
Coffee Break
19
12:15 – 13:00

Science Flash

You have an idea you want to place on the market? You have an outstanding new finding you want to present? be precise and be to the point in a powerful speed presentation.


Plenary
Lunch Break & Poster Session
20
14:00 – 15:30

Closing Lecture “Bridging Tomorrow”

Join in and have a look to the upcoming trends in biotechnology for the next decades. What are the visions of the industry and which disruptive technologies might influence or support the missions of tomorrow? Let’s shed a light on innovative views from representatives in the field of industrial biotechnology.

Speakers:
Marcel Wubbolts (Corbion)
Thomas Haas (Evonik Creavis)

Plenary
15:30

Closing Remarks

Allahverdiyeva-Rinne Yagut

Professor at University of Turku (Finland)

Obtained a PhD degree in Azerbaijan in 2001. Research interests have been mainly focused on basic and applied photosynthesis.
Currently acting as Associated Professor of Molecular Plant Biology, University of Turku, Finland.
A vice-chair of the Nordic Center of Excellence “Towards Versatility of Aquatic Production Platforms: Unlocking the Value of Nordic Bioresources” (NordAqua) funded by NordForsk (2017-2022).
More Information

Arslan Ayla

Professor at International University of Sarajevo (Bosnia and Herzegovina)

Ayla Arslan was born in Istanbul in 1974. She received her MS degree in Biotechnology at the Middle East Technical University. Then, she was awarded by PhD scholarship (DFG, Germany) and completed her doctorate at Heidelberg University in the field of Molecular Biology and Neuroscience. She has been engaged in research and/or university teaching in Europe, Turkey and USA. At present she is Associate Professor at Genetics and Bioengineering Program, International University of Sarajevo in Bosnia and Herzegovina. The expertise and interests of Dr. Arslan range from Molecular Neuroscience, Research strategies in psychiatry to Science and Society, with a specific focus on bio-entrepreneurship.
More Information

Azevedo Ana

Assistant Professor at University of Lisbon (Portugal)

Ana Azevedo is assistant professor at the Department of Bioengineering of Instituto Superior Técnico (IST), University of Lisbon. She graduated in Chemical Engineering from IST-ULisbon in 1996 and obtained a PhD degree in Biotechnology in 2004. She is also senior investigator of the Institute of Bioengineering and Biosciences (iBB) where she coordinates several projects and PhD thesis in downstream processing. Her current research interest are integrating bioseparations and microfluidics to speed process development.
More Information

Bühler Bruno

Group leader at the UFZ in Leipzig (Germany)
Professor at the Martin-Luther University Halle-Wittenberg (Germany)


Bruno Bühler studied biology and biotechnology and did his PhD at ETH Zurich (2003), where he was awarded the ETH medal for outstanding PhD theses. After a postdoctoral period at ETH, he joined the TU Dortmund as group leader for habilitation. In 2015, he became Professor in a common appointment of the Helmholtz Centre for Environmental Research - UFZ in Leipzig and the Martin-Luther-University Halle-Wittenberg.
More Information

Burgard Christian

CSO, Chief Scientific Officer at Arthro Kinetics Biotechnology GmbH

Christian Burgard studied chemistry at the University of Kaiserslautern and made his thesis at the University Hospital of Homburg. He has been working in medical technology for 19 years, ia. at Stryker and Aesculap, and for 15 years in biotechnology. Since 2010 at Arthro Kinetics Biotechnology GmbH. At AKI, as CSO, he is also responsible for spin-offs.
More Information

Chen George Guo-Qiang

Funding Director at the Center of Synthetic and Systems Biology, Tsinghua University (China)
Professor at the School of Life Sciences, Tsinghua University (China)
Chair Professor at Manchester Institute of Biotechnology (England)


Professor George Guo-Qiang Chen received his BSc and PhD from South China University of Technology in 1985 and Graz University of Technology (Austria) in 1989, respectively. He also conducted research in 1990-1994 as a postdoc at University of Nottingham in UK and University of Alberta in Canada, respectively. He has been focusing his research on microbial materials polyhydroxyalkanoates (PHA) metabolic engineering, synthetic biology and PHA biomaterial application since 1986. After joining Tsinghua University in 1994, he has been actively promoting the microbial Bio- and Material Industries in China.
Professor Chen has more than 30 years of R&D experiences on microbial physiology, microbial PHA production and applications, has published over 300 international peer reviewed papers with over 16,000 citations (H-Index 61) as reported in Web of Science. With over 35 issued patents and 45 pending patents, Prof. Chen’s technologies have been provided to several companies that succeeded in mass production of microbial polyhydroxyalkanoates (PHA).
Since 2014, he has been appointed as Chair Professor of Synthetic biology, Manchester University/UK. He has received many awards for his contributions to the microbial manufacturing fields. Beginning from 2015, he becomes the Funding Director of the Center for Synthetic and Systems Biology in Tsinghua University.
More Information

Dallemagne Damien

Secretary General CO2 Value Europe (Belgium)

Damien Dallemagne holds an Engineering degree from the University of Liège, an MSc in Environmental Technology from the Imperial College in London and an MBA from the University of California in Berkeley.
Damien has had a dual career in industry (for 8 years) and in management consulting for more than 16 years (first with Arthur D. Little, then as a free-lance consultant).
Over the last 10 years, Damien has been mostly active in the fields of innovation management and sustainable development. Over recent years, Damien has been particularly involved in accompanying the development of multi-stakeholder innovation networks associating large industrial companies, SMES, research organizations, universities, and public institutions. For example, he played a key role in coaching the creation of the European Knowledge & Innovation Community (KIC) on Raw Materials.
Damien coordinated the efforts that lead to the creation of CO2 Value Europe, the European Association dedicated to CO2 Utilization in November 2017, and has been Secretary General of the Association since then.
More Information

Dürkop Mark

CEO Novasign
Postdoctoral researcher at the University of Natural Resources and Life Science Vienna


With more than nine years of experience, Mark is a passionate scientist in the field of biopharmaceutical process development. Together with his team, he is currently developing a software for both up and downstream processes. This software utilizes process data and first principle models (hybrid models) to quickly predict critical quality attributes from critical process parameters. Hereby, bioprocess development and characterization is accelerated significantly while simultaneously a better process understanding is gathered. From this research project the company “Novasign” was founded in 2019.
More Information

Ebenschweiger Anja

Head of Building Segment Lafarge Zementwerke GmbH (Austria)

Following my study of Gesteinshüttenwesen at the Montanuniversität Leoben my professional life has taken me through various positions at Lafarge Zementwerke GmbH in Austria including quality and environment management for the cement plant, product portfolio management and product development for a country cluster up to my current main project that deals with the cement based mineral insulation called AIRIUM.
More Information

Eckermann Christian

Senior Vice President and Site Head Biopharma (Austria)

Dr. Christian Eckermann has 20 years of experience in Biopharmaceutical Research, Development, Manufacturing and Quality. He is currently heading the Biopharma Site in Vienna, Austria and responsible for all microbial CMC development and large scale production activities for BI own products (New Biological Entities) and Contract Manufacturing Business.
Before moving to Austria in 2013, Christian was 10 years in various functions at Boehringer in Process Science and Operations, latest being responsible for successful product transfers, scale up, clinical and market supply of biopharmaceutical medicines at Biberach, Germany.
Christian has written several publications, holds different patents and developed the trademark protected RAPPtor® technology platform
More Information

Emerencia Nelo

Director Programming at Bio-based Industries Consortium (Belgium)

After a career in the multinational chemicals industry, Nelo Emerencia became Director Programming at the Bio-based Industries Consortium in April 2015. In addition, within the framework of the EU Thematic Smart Specialisation platforms for interregional innovation projects, he coordinates the Bio-Economy partnership.
Nelo studied Chemical Engineering at Delft University of Technology in the Netherlands before returning to Aruba, his native island, where he worked at the Esso refinery and progressed to Marketing Manager. In 1985, Nelo transitioned to the chemicals business in Rotterdam and later Brussels, holding positions in economics and planning, marketing and public affairs. Following a secondment to PlasticsEurope in Brussels as Communications and Public Affairs Director, he returned to ExxonMobil as Public Affairs Manager for the Netherlands. Between 2006 and 2014, he worked at the Dutch Chemical Industry Association in the positions of Education & Innovation Manager and Secretary of the Dutch Chemistry Board. During this assignment Nelo led the bio-based economy activities for the chemical industry and the required curricula developments to support the chemical industry of the future.
More Information

Ferreira Bruno

CEO of Biotrend SA

Bruno Sommer Ferreira, co-founder and CEO of Biotrend. Chemical Engineer, PhD in Biotechnology. More than 20 years experience in the development, optimization and scale-up of bioprocesses based on biological systems as diverse as microalgae, bacteria, yeasts and animal cells. Performed research at the Technical University of Lisbon and the University of Toronto. Consultant and advisor for private and governmental organizations in the topic of industrial biotechnology and bio-based products.
More Information

Gram Anders

Head of process and product development at Indigo Ag (USA)

Anders Gram studied chemical engineering and obtained his PhD in 1987 from the Danish Technical University in collaboration with Novo Industri A/S.
He joined Novo as an expert in Downstream Processing and his career rapidly advanced in the enzyme business, later to become Novozymes. From 95-03 he was a member of the R&D leadership team and ran the development function, responsible for the process and product development of more than 15 new commercial enzymes including lipases, amylases, cellulases and proteases. He was also directly responsible for major optimization projects, leading to more than 2X volumetric productivity of Novozymes’ full portfolio of enzyme products.
Anders Gram then went on to participate in developing a new business unit in Novozymes, developing and scaling up new molecular entities for the pharmaceutical industry.
After Novozymes, he successfully led Bavarian Nordic through industrialization and approval by the FDA of its smallpox vaccine, Imvamune®. Then he joined Chr. Hansen A/S and supervised the production of human probiotics for a number of years, before moving to Boston, where he currently works as head of process and product development for Indigo Ag, a 5-year old startup company in the plant microbiome field. Indigo has developed, tested and commercialized 8 totally new microbial seed treatments. www.indigoag.com.
Anders Gram is deeply and broadly experienced in microbial manufacturing and scale up, he has successfully developed and commercialized numerous new microbially derived products as well as numerous live microorganisms.
More Information

Haas Thomas

Vice President Science & Technology Evonik Creavis GmbH (Germany)


Dr. Thomas Haas was born in Viernheim, Germany. He earned a diploma and PhD in technical chemistry from Darmstadt Technical University. He completed his post-doctoral studies at the Queen Mary College and Imperial College in London.
He was head of research lab “organic intermediates” at Degussa AG, leading the process development of three major chemical specialities, which were implemented in new chemical production plants, 1.3 propane diol, isophorone diamine and para bisamino cyclohexyl amine. In 1999 has took over the responsibility of R&D “bleaching chemicals” of Degussa. During this time he developed the new HPPO process which was implemented the first time 2006 in Ulsan/Korea. In 2007 he took over the responsibility for the strategic biotechnology R&D of Evonik Industries. Currently, he is vice president of science and technology in the strategic R&D unit of Evonik, Creavis GmbH.

More Information

Heijstra Björn D.

Senior Manager, Process Systems Biology at LanzaTech (USA)

Björn is a microbiologist, studied Molecular Microbiology at the Vrije Universiteit in Amsterdam, NL and obtained a PhD from Auckland University, NZ. Currently leads the Process Validation team at LanzaTech on the northside of Chicago, USA. Over the last 10 years he has been involved in the development and scaling up of the LanzaTech gas fermentation process. This accumulated into the first full commercial facility startup in May 2018 at a Shougang steel mill in China. The next commercial plant is under construction near Gent, Belgium.
More Information

Herrgard Markus

Professor and Director of Data Science and Automation at Novo Nordisk (Denmark)

Markus Herrgard is Director of Data Science and Automation at the Novo Nordisk Foundation Center for Biosustainability. In this role he is responsible for developing data science and automation infrastructure to support basic and commercialization-oriented research. His research work is focused on data science for cell factory development including high-throughput omics data generation, mining and visualization of big biological datasets, and genome-scale modeling for cell factory design.
More Information

Höglinger Andrea

Head of Division European and International Programmes at FFG (Austria)

Andrea Höglinger is Head of Division European and International Programmes at the Austrian Research Promotion Agency (FFG) and acts as the Austrian NCP-Coordinator (National Contact Point Coordination) for Horizon 2020. She is an expert in European research funding programmes and worked for almost 10 years as National Contact Point for the Social Sciences and Humanities at an European level. Andrea Höglinger holds a degree in Social and Economic Sciences from the University of Vienna. Before she joined the FFG she had worked for a private research organisation in Austria for serveral years.
More Information

Künkel Andreas

Vice President at BASF, Biopolymer Research (Germany)

Andreas Künkel is head of biopolymer research of BASF. The focus of biopolymer research is the fundamental understanding of the biodegradation process in different environments and the development of new biodegradable and biobased polyesters and compounds for different applications.
After his Ph.D. in microbiology at the Max Planck Institute for terrestrial microbiology in Marburg, he started his BASF career within the Central R&D department, followed by marketing positions for Fine Chemicals and ecoflex® & ecovio® with focus on strategy and New Business Development.
Since starting in BASF in 1999, his focus has been the strategic development and marketing of chemicals and polymers based on renewable resources using the synergies between classical chemistry and biotechnology. Teaching at the University of Marburg gives him constant contact to the next generation.
More Information

Lindley Nic

Director A*STAR Biotransformation Innovation Platform (Singapore)
Senior CNRS Research Director at Toulouse Biotechnology Institute (France)


Dr. Lindley has been actively developing an integrated pipeline coupling strain development via metabolic engineering to process technology innovation for many years and was leading the Toulouse LISBP laboratory until 2015. He then moved to Singapore where he developed the A*STAR Biotransformation Innovation Platform taking it from a concept to a functional 50-person research entity, undertaking industry-facing R&D for food and consumer care speciality ingredients. From August 2019, he splits his time between the laboratories in Toulouse (TBI and TWB) and Singapore (BioTrans).
More Information

Nielsen Jens

Professor at Chalmers University of Technology (Sweden)

Jens Nielsen has a PhD degree (1989) from DTU, and was appointed full Professor there in 1998. In 2008 he was recruited as Professor to Chalmers, Sweden, and in 2019 as CEO of the BioInnovation Institute in Denmark. Jens Nielsen has published so far more than 700 papers that have been cited more than 60,000 times (current H-factor 113). He is inventor of more than 50 patents and he has founded several biotech companies. He is member of the several academies including National Academy of Sciences, National Academy of Engineering and Royal Swedish Academy of Sciences.
More Information

Palmberger Dieter

Senior Scientist at acib GmbH (Austria)

Dieter Palmberger is a Senior Scientist at acib GmbH dealing with upstream bioprocess development. He has deep knowledge in development of scalable platform processes for the production of viral vaccines and in process development for the production of clinical phase III material. Before, he was a PostDoc at BOKU, where he also finished his PhD and where he was working on systems development in baculovirus and insect cells. From 2012 to 2016 he was holding a FWF grant for “Influenza HA and the importance of glycosylation”.
More Information

Panek Julita

Consultant Pharma Siemens AG (Austria)

Julita Panek completed her PhD at the University of Natural Resources and Life Sciences Vienna in the field of biotechnology under supervision of Prof. Alois Jungbauer. Julita has been involved in process development, manufacturing production and PAT activities for the past 10 years at Bristol Myers Squibb, Sandoz and Shire. In her last position in the biopharmaceutical industry, Julita was responsible for establishment of global PAT strategy. Her current focus at Siemens is support and consulting for biotech and pharma manufacturers in development and implementation of long-term strategic digitalization concepts.
More Information

Pasecinic Nicoleta

Regulatory Affairs Manager at Pen & Tec Consulting S.L.U. (Spain)

Nicoleta Pasecinic is a nutritionist by background, having graduated in Food and Human Nutrition from Newcastle University, UK. She also holds a Bachelor degree in Marketing, specialising in B2B sales. Nicoleta has over 2 years’ experience with working in the food and feed regulatory industry, helping clients worldwide to bring their products onto the global market as fast and as economically as possible. Nicoleta is an expert in EU novel food authorisations and novel food consultations as well as successfully leading novel food enzyme applications in the EU and achieving approval of probiotic strains in the US. She has experience in study design, data analysis and interpretation and is an author of two published scientific studies.
More Information

Pereira Aguilar Patricia

PhD Student (staff scientist) at the University of Natural Resources and Life Sciences, Vienna (Austria)

Patricia has a Bachelor and Master degree in Biotechnology at the University of Beira Interior (Covilhã, Portugal). Currently she is finalizing the PhD within the International PhD Program in Protein Biotechnology (BioTop) at the University of Natural Resources and Life Sciences, Vienna, Austria. Supervised by Professor Alois Jungbauer, the project aims to understand the partitioning of virus-like particles in charged hydrogels and establish directed process development for virus-like particles downstream.
More Information

Phillips Michael

Director of the Next Generation BioProcessing R&D team at Merck (Germany)

Dr. Michael Phillips is currently the Director of the Next Generation BioProcessing R&D team at Merck focused on Applications and Innovation supporting the BioContinuum™ Platform. He is responsible for identifying, developing, and implementing innovative upstream and downstream processing technologies, novel process analytical technologies and sensors, and advanced software and automation that enable process intensification for mAb processing, including integrated, connected, and continuous processing. Dr. Phillips has more than 28 years of experience at Merck developing new bioprocess technologies and applications. Dr. Phillips holds a PhD in chemical engineering from Rensselaer Polytechnic Institute.
More Information

Posch Andreas E.

CEO Ares Genetics GmbH (Austria)

Andreas is the founding CEO of Ares Genetics, a developer of artificial intelligence powered infectious disease diagnostics since 2017. Prior to his current position, he was responsible for global bioinformatics R&D at Siemens Healthcare where he developed Ares Genetics’ core technology for next-generation sequencing based drug response detection. He has an academic background in bioinformatics and biotechnology and his work was recognized by international awards and several million Euro funding from competitive research grants.
More Information

Reiter Katrin

Junior Scientist at the University of Natural Resources and Life Sciences, Vienna (Austria)

Katrin obtained her Master degree in Food Science and Technology at the University of Natural Resources and Life Sciences, Vienna. She wrote her Master thesis in method development on UHPLC for quantitative determination of vitamins in milk. She is currently finalizing her PhD at University of Natural Resources and Life Sciences, Vienna under the supervision of Professor Alois Jungbauer. Aim of the thesis is the establishment of a downstream process of influenza virus-like particles produced in insect cell culture.
More Information

Rottensteiner Hanspeter

Head of Research Gene Therapy, Drug Discovery (Austria)

Dr. Hanspeter Rottensteiner currently serves as Head of Research Gene Therapy at Takeda’s Drug Discovery Center Austria. He is a biochemist by training with more than 20 years of experience in conducting scientific research in the fields of Biochemistry and Molecular Cell Biology. Over the last 10+ years he contributed to the development of biologics for hematology indications and is now leading Shire’s gene therapy programs for hemophilia and other rare diseases.
More Information

Savile Chris

Vice President, Commercial Operations Willow Biosciences Inc. (USA)

Chris Savile joined Willow Biosciences in 2019 as Vice President of Commercial Operations, where he is focused on developing and commercializing microbial fermentation routes to plant-derived compounds. Chris received his Ph.D. in organic chemistry with a focus in Biocatalysis from McGill University (Montréal, Québec) in 2005. In 2006, he joined Codexis, Inc. where he was a Staff Scientist and then Senior Scientist in the HTP Assay Development Group, and then Associate Director of Business Development in their Pharmaceuticals business unit. He then joined Intrexon’s Industrial Products Division in 2015, where he led their Fine Chemicals programs as Executive Director of Commercial Operations.
More Information

Schloter Michael

Head of Department for Comparative Microbiome Analysis at the Helmholtz Zentrum (Germany)

Michael Schloter is heading the Department for Comparative Microbiome Analysis at the Helmholtz Zentrum in Munich and hold a Professorship for Microbiology at the Technical University of Munich. His major interest is to improve the understanding on general principles of microbiome formation as well as host - microbe imteractions. His main research focus is the analysis of interactions of environemta- and human microbiomes as well as consequences for human health.
More Information

Sladek Barbara

CEO and Founder of myBioma GmbH (Austria)

Barbara Sladek has a PhD in biochemistry at University of Oxford. She gained experience as business manager at Siemens Healthineers. Barbara Sladek founded myBioma GmbH together with Dr. Nikolaus Gasche.
More Information

Snajdrova Radka

Group leader at Novartis Institute for Biomedical Research (Switzerland)

Radka obtained her PhD from Vienna University of Technology and Institute of Chemical Technology Prague in 2007 where she worked on the asymmetric synthesis of lactones using a combination of chemical and biocatalytic approaches. She received an Erwin-Schroedinger Fellowship and spent 1 year of postdoctoral study at York University in the UK, exploring the development of novel biocatalysts for organosilane chemistry. In 2009, Radka moved to University of Greifswald, Germany as a senior postdoctoral fellow to develop a high-throughput screening approach for in vivo selection and cell sorting, with the primary goal of identifying novel enantioselective enzymes.
In 2011, she transitioned to industry with a [one year role at a lab focussed on supporting chemists at GSK to take advantage of biocatalytic technologies (Novacta)], prior to directly joining Chemical Process Development at GSK, UK as Project leader responsible for the development and implementation of new biocatalytic technology in both pre- and post-commercialisation routes.
Since Dec 2016, Radka is leading the Biorecations group in Global Discovery Chemistry at Novartis Institute for Biomedical Research in Basel, supporting medicinal chemists, process chemists and pharmacokinetics studies with biocatalytic solutions. She is author of >30 scientific publications and book chapters in biocatalysis. Radka received recently the EFMC Award for Young Investigator in Industry (2019).
More Information

Takano Eriko

Professor of Synthetic Biology at University of Manchester (England)

Eriko Takano has been Professor of Synthetic Biology in the Manchester Institute of Biotechnology at the University of Manchester since 2012. In 2014, she was appointed as one of the three directors for the EPSRC/BBSRC-funded Manchester Synthetic Biology Research Centre, SYNBIOCHEM and in 2018, she was appointed as the deputy head of School of Chemistry. Eriko graduated from Kitasato University in Japan and did her undergraduate project with Prof Satoshi Omura (2015 Nobel Prize in Physiology and Medicine), before working at a R&D facility for a company, Meiji Seika Kaisha, for several years. After leaving industry, she obtained her PhD at the John Innes Institute, Norwich, UK, in 1994. Before her arrival in Manchester, she had been Associate Professor at the University of Groningen, The Netherlands, and Assistant Professor (C1) at the Department of Microbiology / Biotechnology, University of Tübingen, in Germany.
Eriko is internationally recognized as a pioneer in the synthetic biology of microbes for antibiotic production. Her interests are in bioinformatics software development for designing natural products producers; untargeted metabolomics for chassis engineering in Streptomyces; secondary metabolite biosynthesis pathway assembly; and regulatory circuit engineering through signalling molecules and non-coding RNAs. Eriko has published 99 peer-reviewed papers and 4 book chapters and holds 4 international patents.
She is an Associate Editor for ACS Omega and has been an expert advisor for the European Commission Scientific Committee on Emerging and Newly Identified Health Risks on synthetic biology, where she contributed to a series of three official Opinions with major impact on the development of the field.
More Information

von Stosch Moritz

Director of Process Validation at GSK Vaccines (Belgium)

Moritz von Stosch leads the Process Systems Biology and Engineering Center of Excellence at the Technical R&D department of GSK Vaccines, Belgium. He is a process systems engineer by education with a Diplom in Chemical Engineering from the RWTH-Aachen University and PhD in Biochemical Engineering from the University of Porto. Before joining GSK, Moritz worked as a Lecturer at Newcastle University, where his research focused on the development of novel hybrid modeling methods that combine process understanding with data knowledge as well as their application to enable more efficient process operation/design.
More Information